MarketInOut Stock Screener Log In | Sign Up

CRISPR Therapeutics AG

NASDAQ • Healthcare • Biotechnology • Quote as of 11/20/2026
CRISPR Therapeutics AG stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,792.73 mln
Float90.05 mln
Earnings Date02/16/2027

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-3.9
Highly reliable

1-Year Forecast

85.42
Transformational upside

Relative Strength

17 / 100
Significantly lagging

Debt / Equity

0.47
Low leverage

Pre-Tax Margin

-1,802%
Severely loss-making

Business Description

CRISPR Therapeutics AG is a Swiss biotechnology company founded in 2013 that develops treatments for serious diseases by precisely modifying patients' DNA. Its most advanced product, CASGEVY, has been approved to treat sickle cell disease and beta-thalassemia by editing a patient's own stem cells to restore healthy red blood cell function. The company is also advancing a broad pipeline of therapies targeting blood disorders, cancer, autoimmune conditions, cardiovascular disease, and type 1 diabetes, with key programs built around engineered immune cell treatments and direct gene correction inside the body. CRISPR Therapeutics works alongside Vertex Pharmaceuticals and operates from its headquarters in Zug, Switzerland.

Key Fundamentals

EPS-4.73
ROE-25.21
RPS0.26
ROIC-154
ROA-18.33
EBITDA, mln-435
EV / EBITDA-7.90
EV / EBIT-7.58
Revenue, mln25.17
EV / Revenue137

Quote Details

Last 39.10
Change 0.17 (0.44%)
Open 38.18
Volume 3,316,273
Turnover 129,666,272
Average Volume 2,127,270

Financial Ratios

Pre-Tax Profit Margin-1,802
Leverage Ratio1.55
Current Ratio16.21
Price / Book3.00
Price / Tangible Book3.00
Debt / Equity0.47
Price / Sales196

Financial Strength

Altman Z-Score2.38
Piotroski F-Score 2 / 9
Beneish M-Score-3.9
1-Year Target Price85.42
Short Ratio11.65
Short % of Float20.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.43% 49 / 100   
1 Month -21.78% 25 / 100   
2 Months -27.97% 29 / 100   
6 Months -22.36% 34 / 100   
1 Year -22.93% 30 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog